SuPAR, an emerging biomarker in kidney and inflammatory diseases
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ Publishing Group
Abstract
Soluble urokinase plasminogen activator receptor (suPAR) is a circulating form of a physiological and pathophysiological important cell surface receptor, implicated in inflammation. Recent studies showed that suPAR is a promising biomarker, useful for diagnosis, assessment and prognosis of several diseases. This review summarises the majority of preliminary studies and analyses the significance and the clinical application of suPAR in various clinical conditions. SuPAR seems to have a significant value in the diagnosis as well as prognosis of many diseases; nonetheless, it merits large-scale studies to set cut-off values that help physicians in following up their patients and accordingly tailor their treatment plans. © Author(s) (or their employer(s)) 2018. No commercial re-use. See rights and permissions. Published by BMJ.
Description
Keywords
Biomarker, Diagnosis, Inflammation, Prognosis, Screen, Soluble urokinase plasminogen activator receptor, Biomarkers, Humans, Kidney diseases, Receptors, urokinase plasminogen activator, C reactive protein, Plasmin, Plasminogen, Procalcitonin, Proteinase, Urokinase receptor, Biological marker, Acute myeloid leukemia, Acute pancreatitis, Atherosclerosis, Diabetes mellitus, Diabetic nephropathy, Disease severity, End stage renal disease, Estimated glomerular filtration rate, Focal glomerulosclerosis, Glomerulopathy, Human, Human immunodeficiency virus infection, Immunoglobulin a nephropathy, Inflammatory disease, Intensive care unit, Interstitial nephritis, Kidney disease, Liver cell carcinoma, Liver cirrhosis, Liver fibrosis, Membranous glomerulonephritis, Multiple myeloma, Non st segment elevation myocardial infarction, Peripheral occlusive artery disease, Plasmapheresis, Proteinuria, Pulmonary hypertension, Renin angiotensin aldosterone system, Review, Rheumatoid arthritis, Sepsis, St segment elevation myocardial infarction, Systemic lupus erythematosus, Systemic sclerosis, Blood